Regulatory Confusion Reigns As FDA Grapples With CBD
By Erik Goldman, Editor in Chief
On July 30, former FDA Commissioner, Scott Gottlieb, published an op/ed in the Washington Post entitled, “The CBD craze is getting out of hand. The FDA needs to act.”
It’s a massive understatement given that there are now well over 1,000 companies selling supplements, foods, beverages, cosmetics, confections—even room diffusers—claiming to contain CBD. They promise myriad health benefits, most of which cannot be substantiated.
It’s also an ironic statement, coming as it does, from a man whose two-year tenure at the FDA will be remembered—rightly or wrongly—as the dawn of “legal” cannabis products.
[ ...Read More ]